The use of spirocyclic scaffolds in drug discovery

被引：835

作者：

Zheng, Yajun ^{[1
]}

Tice, Colin M. ^{[1
]}

Singh, Suresh B. ^{[1
]}

机构：

[1] Vitae Pharmaceut Inc, Ft Washington, PA 19034 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 16期

关键词：

Spirocyclic; Scaffold; Drug discovery; 1; BACE1; INHIBITORS; MACROCYCLIC INHIBITORS; UREA DERIVATIVES; RECEPTOR LIGANDS; INVERSE AGONISTS; POTENT; DESIGN; OPTIMIZATION; BETA; IDENTIFICATION;

D O I：

10.1016/j.bmcl.2014.06.081

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery. In this brief review, we highlight selected examples from the primary medicinal chemistry literature during the last three years to demonstrate the versatility of spiro scaffolds. With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery. (C) 2014 The Authors. Published by Elsevier Ltd.

引用

页码：3673 / 3682

页数：10

共 50 条

[21] Privileged scaffolds for library design and drug discovery
Welsch, Matthew E.
Snyder, Scott A.
Stockwell, Brent R.
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) : 347 - 361
[22] Privileged Scaffolds in Natural Products and Drug Discovery
Sun, Dianqing
Guendisch, Daniela
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (11) : 1199 - 1199
[23] Polycyclic Sulfoximines as New Scaffolds for Drug Discovery
Borst, Mark L. G.
Ouairy, Cecile M. J.
Fokkema, Sander C.
Cecchi, Alessandro
Kerckhoffs, Jessica M. C. A.
de Boer, Vincent L.
van den Boogaard, Peter J.
Bus, Rutger F.
Ebens, Rijko
van der Hulst, Rob
Knol, Joop
Libbers, Rob
Lion, Zhou M.
Settels, Bart W.
de Weyer, Ellen
Attia, Khaled A.
Sinnema, Piet-Jan
de Gooijer, Jesse M.
Harkema, Karen
Hazewinkel, Marieke
Snijder, Susan
Pouwer, Kees
ACS COMBINATORIAL SCIENCE, 2018, 20 (06) : 335 - 343
[24] Carbohydrate-based scaffolds in drug discovery
Becker, Bernd
Condie, Glenn C.
Le, Giang Thanh
Meutermans, Wirn
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (12) : 1299 - 1309
[25] The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery
Barnes, Emma C.
Kumar, Rohitesh
Davis, Rohan A.
NATURAL PRODUCT REPORTS, 2016, 33 (03) : 372 - 381
[26] Biopharmaceutical drug discovery using novel protein scaffolds
Gill, Davinder S.
Damle, Nitin K.
CURRENT OPINION IN BIOTECHNOLOGY, 2006, 17 (06) : 653 - 658
[27] Betidamino acids: Versatile and constrained scaffolds for drug discovery
Rivier, JE
Jiang, GC
Koerber, SC
Porter, J
Simon, L
Craig, AG
Hoeger, CA
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 2031 - 2036
[28] Synthesis of 4-aminotetrahydropyran scaffolds for drug discovery
Nortcliffe, Andrew
Milne, Gavin D. S.
Hamza, Daniel
Moody, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (07) : 2218 - 2225
[29] A guide for the synthesis of key nucleoside scaffolds in drug discovery
Dinithi G. Rajapaksha
Subhojit Mondal
Jason W. Wang
Michael W. Meanwell
Medicinal Chemistry Research, 2023, 32 : 1315 - 1333
[30] Natural product derived privileged scaffolds in drug discovery
Davison, Emma K.
Brimble, Margaret A.
CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 52 : 1 - 8

← 1 2 3 4 5 →